ReP USP - Resultado da busca

Artigo de periodico-carta/editorial
Soluble urokinase plasminogen activator receptor (suRAR) levels. [Editorial]: underscoring the link between low educational attainment and death among coronary artery disease patients (2024)
Coelho, Otavio R; Santos Filho, Raul Dias dos
Source: European journal of preventive cardiology. Unidade: FM
Subjects: DOENÇAS CARDIOVASCULARES, ESCOLARIZAÇÃO, MORTALIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COELHO, Otavio R e SANTOS FILHO, Raul Dias dos. Soluble urokinase plasminogen activator receptor (suRAR) levels. [Editorial]: underscoring the link between low educational attainment and death among coronary artery disease patients. European journal of preventive cardiology. Oxford: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://observatorio.fm.usp.br/handle/OPI/76877. Acesso em: 22 jan. 2026. , 2024
APA
Coelho, O. R., & Santos Filho, R. D. dos. (2024). Soluble urokinase plasminogen activator receptor (suRAR) levels. [Editorial]: underscoring the link between low educational attainment and death among coronary artery disease patients. European journal of preventive cardiology. Oxford: Faculdade de Medicina, Universidade de São Paulo. doi:10.1093/eurjpc/zwad346
NLM
Coelho OR, Santos Filho RD dos. Soluble urokinase plasminogen activator receptor (suRAR) levels. [Editorial]: underscoring the link between low educational attainment and death among coronary artery disease patients [Internet]. European journal of preventive cardiology. 2024 ; 31( 5): 519-520.[citado 2026 jan. 22 ] Available from: https://observatorio.fm.usp.br/handle/OPI/76877
Vancouver
Coelho OR, Santos Filho RD dos. Soluble urokinase plasminogen activator receptor (suRAR) levels. [Editorial]: underscoring the link between low educational attainment and death among coronary artery disease patients [Internet]. European journal of preventive cardiology. 2024 ; 31( 5): 519-520.[citado 2026 jan. 22 ] Available from: https://observatorio.fm.usp.br/handle/OPI/76877
Artigo de periodico-carta/editorial
Vaccine hesitancy in patients with autoimmune diseases. [Carta]: data from the coronavirus disease-2019 vaccination in autoimmune diseases study (2022)
Sen, Parikshit; Lilleker, James B; Agarwal, Vishwesh; Kardes, Sinan; Milchert, Marcin; Gheita, Tamer; Salim, Babur; Velikova, Tsvetelina; Gracia-Ramos, Abraham Edgar; Shinjo, Samuel Katsuyuki
Source: Indian journal of rheumatology. Unidade: FM
Subjects: DOENÇAS AUTOIMUNES, COVID-19, VACINAS VIRAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SEN, Parikshit et al. Vaccine hesitancy in patients with autoimmune diseases. [Carta]: data from the coronavirus disease-2019 vaccination in autoimmune diseases study. Indian journal of rheumatology. Mumbai: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.4103/injr.injr_221_21. Acesso em: 22 jan. 2026. , 2022
APA
Sen, P., Lilleker, J. B., Agarwal, V., Kardes, S., Milchert, M., Gheita, T., et al. (2022). Vaccine hesitancy in patients with autoimmune diseases. [Carta]: data from the coronavirus disease-2019 vaccination in autoimmune diseases study. Indian journal of rheumatology. Mumbai: Faculdade de Medicina, Universidade de São Paulo. doi:10.4103/injr.injr_221_21
NLM
Sen P, Lilleker JB, Agarwal V, Kardes S, Milchert M, Gheita T, Salim B, Velikova T, Gracia-Ramos AE, Shinjo SK. Vaccine hesitancy in patients with autoimmune diseases. [Carta]: data from the coronavirus disease-2019 vaccination in autoimmune diseases study [Internet]. Indian journal of rheumatology. 2022 ; 17( 2): 188-191.[citado 2026 jan. 22 ] Available from: https://doi.org/10.4103/injr.injr_221_21
Vancouver
Sen P, Lilleker JB, Agarwal V, Kardes S, Milchert M, Gheita T, Salim B, Velikova T, Gracia-Ramos AE, Shinjo SK. Vaccine hesitancy in patients with autoimmune diseases. [Carta]: data from the coronavirus disease-2019 vaccination in autoimmune diseases study [Internet]. Indian journal of rheumatology. 2022 ; 17( 2): 188-191.[citado 2026 jan. 22 ] Available from: https://doi.org/10.4103/injr.injr_221_21
Artigo de periodico
Stroke prevention in patients from Latin American countries with non-valvular atrial fibrillation: Insights from the GARFIELD-AF registry (2019)
Jerjes-sanchez, Carlos; Corbalan, Ramon; Barretto, Antonio Carlos Pereira; Luciardi, Hector L; Allu, Jagan; Illingworth, Laura; Pieper, Karen S; Kayani, Gloria
Source: Clinical cardiology. Unidade: FM
Subjects: ACIDENTE VASCULAR CEREBRAL, FIBRILAÇÃO ATRIAL, ANTICOAGULANTES, AMÉRICA LATINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JERJES-SANCHEZ, Carlos et al. Stroke prevention in patients from Latin American countries with non-valvular atrial fibrillation: Insights from the GARFIELD-AF registry. Clinical cardiology, v. 42, n. 5, p. 553-560, 2019Tradução . . Disponível em: https://doi.org/10.1002/clc.23176. Acesso em: 22 jan. 2026.
APA
Jerjes-sanchez, C., Corbalan, R., Barretto, A. C. P., Luciardi, H. L., Allu, J., Illingworth, L., et al. (2019). Stroke prevention in patients from Latin American countries with non-valvular atrial fibrillation: Insights from the GARFIELD-AF registry. Clinical cardiology, 42( 5), 553-560. doi:10.1002/clc.23176
NLM
Jerjes-sanchez C, Corbalan R, Barretto ACP, Luciardi HL, Allu J, Illingworth L, Pieper KS, Kayani G. Stroke prevention in patients from Latin American countries with non-valvular atrial fibrillation: Insights from the GARFIELD-AF registry [Internet]. Clinical cardiology. 2019 ; 42( 5): 553-560.[citado 2026 jan. 22 ] Available from: https://doi.org/10.1002/clc.23176
Vancouver
Jerjes-sanchez C, Corbalan R, Barretto ACP, Luciardi HL, Allu J, Illingworth L, Pieper KS, Kayani G. Stroke prevention in patients from Latin American countries with non-valvular atrial fibrillation: Insights from the GARFIELD-AF registry [Internet]. Clinical cardiology. 2019 ; 42( 5): 553-560.[citado 2026 jan. 22 ] Available from: https://doi.org/10.1002/clc.23176
Artigo de periodico
Addition of radium-223 to abiraterone acetate and prednisone or prednisolone in patients with castration-resistant prostate cancer and bone metastases (ERA 223): a randomised, double-blind, placebo-controlled, phase 3 trial (2019)
Smith, Matthew; Parker, Chris; Saad, Fred; Miller, Kurt; Tombal, Bertrand; Ng, Quan Sing; Boegemann, Martin; Matveev, Vsevolod; Piulats, Josep Maria; Zucca, Luis Eduardo; Nahas, William Carlos
Source: Lancet oncology. Unidade: FM
Subjects: NEOPLASIAS PROSTÁTICAS, METÁSTASE NEOPLÁSICA, NEOPLASIAS ÓSSEAS, ESTEROIDES, ANDRÓGENOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SMITH, Matthew et al. Addition of radium-223 to abiraterone acetate and prednisone or prednisolone in patients with castration-resistant prostate cancer and bone metastases (ERA 223): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet oncology, v. 20, n. 3, p. 408-419, 2019Tradução . . Disponível em: https://doi.org/10.1016/S1470-2045(18)30860-X. Acesso em: 22 jan. 2026.
APA
Smith, M., Parker, C., Saad, F., Miller, K., Tombal, B., Ng, Q. S., et al. (2019). Addition of radium-223 to abiraterone acetate and prednisone or prednisolone in patients with castration-resistant prostate cancer and bone metastases (ERA 223): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet oncology, 20( 3), 408-419. doi:10.1016/S1470-2045(18)30860-X
NLM
Smith M, Parker C, Saad F, Miller K, Tombal B, Ng QS, Boegemann M, Matveev V, Piulats JM, Zucca LE, Nahas WC. Addition of radium-223 to abiraterone acetate and prednisone or prednisolone in patients with castration-resistant prostate cancer and bone metastases (ERA 223): a randomised, double-blind, placebo-controlled, phase 3 trial [Internet]. Lancet oncology. 2019 ; 20( 3): 408-419.[citado 2026 jan. 22 ] Available from: https://doi.org/10.1016/S1470-2045(18)30860-X
Vancouver
Smith M, Parker C, Saad F, Miller K, Tombal B, Ng QS, Boegemann M, Matveev V, Piulats JM, Zucca LE, Nahas WC. Addition of radium-223 to abiraterone acetate and prednisone or prednisolone in patients with castration-resistant prostate cancer and bone metastases (ERA 223): a randomised, double-blind, placebo-controlled, phase 3 trial [Internet]. Lancet oncology. 2019 ; 20( 3): 408-419.[citado 2026 jan. 22 ] Available from: https://doi.org/10.1016/S1470-2045(18)30860-X
Artigo de periodico
Clinical Genetic Testing for Familial Hypercholesterolemia (2018)
Sturm, Amy C.; Santos, Raul D.
Source: Journal of the american college of cardiology. Unidade: FM
Subjects: HIPERCOLESTEROLEMIA, DOENÇAS CARDIOVASCULARES, COLESTEROL, CUSTOS DOS CUIDADOS DE SAÚDE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
STURM, Amy C. e SANTOS, Raul D. Clinical Genetic Testing for Familial Hypercholesterolemia. Journal of the american college of cardiology, v. 72, n. 6, p. 662-680, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.jacc.2018.05.044. Acesso em: 22 jan. 2026.
APA
Sturm, A. C., & Santos, R. D. (2018). Clinical Genetic Testing for Familial Hypercholesterolemia. Journal of the american college of cardiology, 72( 6), 662-680. doi:10.1016/j.jacc.2018.05.044
NLM
Sturm AC, Santos RD. Clinical Genetic Testing for Familial Hypercholesterolemia [Internet]. Journal of the american college of cardiology. 2018 ; 72( 6): 662-680.[citado 2026 jan. 22 ] Available from: https://doi.org/10.1016/j.jacc.2018.05.044
Vancouver
Sturm AC, Santos RD. Clinical Genetic Testing for Familial Hypercholesterolemia [Internet]. Journal of the american college of cardiology. 2018 ; 72( 6): 662-680.[citado 2026 jan. 22 ] Available from: https://doi.org/10.1016/j.jacc.2018.05.044
Artigo de periodico
Prognostic relevance of appropriate renal function evaluation in pulmonary arterial hypertension (2018)
Alves- Jr., Jose Leonidas; Souza, Rogerio
Source: Journal of heart and lung transplantation. Unidade: FM
Subjects: RIM, HIPERTENSÃO PULMONAR, PROGNÓSTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALVES- JR., Jose Leonidas e SOUZA, Rogerio. Prognostic relevance of appropriate renal function evaluation in pulmonary arterial hypertension. Journal of heart and lung transplantation, v. 37, n. 6, p. 692-693, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.healun.2018.02.005. Acesso em: 22 jan. 2026.
APA
Alves- Jr., J. L., & Souza, R. (2018). Prognostic relevance of appropriate renal function evaluation in pulmonary arterial hypertension. Journal of heart and lung transplantation, 37( 6), 692-693. doi:10.1016/j.healun.2018.02.005
NLM
Alves- Jr. JL, Souza R. Prognostic relevance of appropriate renal function evaluation in pulmonary arterial hypertension [Internet]. Journal of heart and lung transplantation. 2018 ; 37( 6): 692-693.[citado 2026 jan. 22 ] Available from: https://doi.org/10.1016/j.healun.2018.02.005
Vancouver
Alves- Jr. JL, Souza R. Prognostic relevance of appropriate renal function evaluation in pulmonary arterial hypertension [Internet]. Journal of heart and lung transplantation. 2018 ; 37( 6): 692-693.[citado 2026 jan. 22 ] Available from: https://doi.org/10.1016/j.healun.2018.02.005
Artigo de periodico
Long-term outcomes of elagolix in women with endometriosis (2018)
Surrey, Eric; Taylor, Hugh S; Giudice, Linda; Lessey, Bruce A; Abrao, Mauricio S; Archer, David F; Diamond, Michael P; Johnson, Neil P; Watts, Nelson B; Gallagher, J. Chris
Source: Obstetrics and gynecology. Conference titles: 73rd Scientific Congress and Expo of the American-Society-for-Reproductive-Medicine (ASRM). Unidade: FM
Subjects: ENDOMETRIOSE, HORMÔNIO LIBERADOR DE GONADOTROFINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SURREY, Eric et al. Long-term outcomes of elagolix in women with endometriosis. Obstetrics and gynecology, v. 132, n. 1, p. 147-160, 2018Tradução . . Disponível em: https://doi.org/10.1097/AOG.0000000000002675. Acesso em: 22 jan. 2026.
APA
Surrey, E., Taylor, H. S., Giudice, L., Lessey, B. A., Abrao, M. S., Archer, D. F., et al. (2018). Long-term outcomes of elagolix in women with endometriosis. Obstetrics and gynecology, 132( 1), 147-160. doi:10.1097/AOG.0000000000002675
NLM
Surrey E, Taylor HS, Giudice L, Lessey BA, Abrao MS, Archer DF, Diamond MP, Johnson NP, Watts NB, Gallagher JC. Long-term outcomes of elagolix in women with endometriosis [Internet]. Obstetrics and gynecology. 2018 ; 132( 1): 147-160.[citado 2026 jan. 22 ] Available from: https://doi.org/10.1097/AOG.0000000000002675
Vancouver
Surrey E, Taylor HS, Giudice L, Lessey BA, Abrao MS, Archer DF, Diamond MP, Johnson NP, Watts NB, Gallagher JC. Long-term outcomes of elagolix in women with endometriosis [Internet]. Obstetrics and gynecology. 2018 ; 132( 1): 147-160.[citado 2026 jan. 22 ] Available from: https://doi.org/10.1097/AOG.0000000000002675
Artigo de periodico
Edoxaban versus warfarin in Latin American Patients with atrial fibrillation the ENGAGE AF-TIMI 48 trial (2018)
Corbalan, Ramon; Nicolau, Jose Carlos
Source: Journal of the american college of cardiology. Unidade: FM
Subjects: ANTICOAGULANTES, FIBRILAÇÃO ATRIAL, ACIDENTE VASCULAR CEREBRAL, AMÉRICA LATINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CORBALAN, Ramon e NICOLAU, Jose Carlos. Edoxaban versus warfarin in Latin American Patients with atrial fibrillation the ENGAGE AF-TIMI 48 trial. Journal of the american college of cardiology, v. 72, n. 13, p. 1466-1475, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.jacc.2018.07.037. Acesso em: 22 jan. 2026.
APA
Corbalan, R., & Nicolau, J. C. (2018). Edoxaban versus warfarin in Latin American Patients with atrial fibrillation the ENGAGE AF-TIMI 48 trial. Journal of the american college of cardiology, 72( 13), 1466-1475. doi:10.1016/j.jacc.2018.07.037
NLM
Corbalan R, Nicolau JC. Edoxaban versus warfarin in Latin American Patients with atrial fibrillation the ENGAGE AF-TIMI 48 trial [Internet]. Journal of the american college of cardiology. 2018 ; 72( 13): 1466-1475.[citado 2026 jan. 22 ] Available from: https://doi.org/10.1016/j.jacc.2018.07.037
Vancouver
Corbalan R, Nicolau JC. Edoxaban versus warfarin in Latin American Patients with atrial fibrillation the ENGAGE AF-TIMI 48 trial [Internet]. Journal of the american college of cardiology. 2018 ; 72( 13): 1466-1475.[citado 2026 jan. 22 ] Available from: https://doi.org/10.1016/j.jacc.2018.07.037
Artigo de periodico-carta/editorial
Survival of connective tissue disease associated pulmonary arterial hypertension (2018)
Assad, A. P. Luppino; Souza, R.; Oleas, F. Gavilanes; Alves Jr., J. L.; Fernandes, C. J. C. dos Santos; Sampaia-Barros, P. D
Source: Clinical and experimental rheumatology. Unidade: FM
Subjects: HIPERTENSÃO PULMONAR, TECIDO CONJUNTIVO, PROGNÓSTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ASSAD, A. P. Luppino et al. Survival of connective tissue disease associated pulmonary arterial hypertension. Clinical and experimental rheumatology. Pisa: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 22 jan. 2026. , 2018
APA
Assad, A. P. L., Souza, R., Oleas, F. G., Alves Jr., J. L., Fernandes, C. J. C. dos S., & Sampaia-Barros, P. D. (2018). Survival of connective tissue disease associated pulmonary arterial hypertension. Clinical and experimental rheumatology. Pisa: Faculdade de Medicina, Universidade de São Paulo.
NLM
Assad APL, Souza R, Oleas FG, Alves Jr. JL, Fernandes CJC dos S, Sampaia-Barros PD. Survival of connective tissue disease associated pulmonary arterial hypertension. Clinical and experimental rheumatology. 2018 ; 36( 4): S186-S186.[citado 2026 jan. 22 ]
Vancouver
Assad APL, Souza R, Oleas FG, Alves Jr. JL, Fernandes CJC dos S, Sampaia-Barros PD. Survival of connective tissue disease associated pulmonary arterial hypertension. Clinical and experimental rheumatology. 2018 ; 36( 4): S186-S186.[citado 2026 jan. 22 ]
Artigo de periodico
Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial) (2018)
Giugliano, Robert P.; Nicolau, Jose Carlos
Source: Circulation. Unidade: FM
Subjects: DIABETES MELLITUS, DOENÇAS CARDIOVASCULARES, FÁRMACOS DO SANGUE E SISTEMA HEMATOPOÉTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GIUGLIANO, Robert P. e NICOLAU, Jose Carlos. Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial). Circulation, v. 137, n. 15, p. 1571-0, 2018Tradução . . Disponível em: https://doi.org/10.1161/CIRCULATIONAHA.117.030950. Acesso em: 22 jan. 2026.
APA
Giugliano, R. P., & Nicolau, J. C. (2018). Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial). Circulation, 137( 15), 1571-0. doi:10.1161/CIRCULATIONAHA.117.030950
NLM
Giugliano RP, Nicolau JC. Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial) [Internet]. Circulation. 2018 ; 137( 15): 1571-0.[citado 2026 jan. 22 ] Available from: https://doi.org/10.1161/CIRCULATIONAHA.117.030950
Vancouver
Giugliano RP, Nicolau JC. Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial) [Internet]. Circulation. 2018 ; 137( 15): 1571-0.[citado 2026 jan. 22 ] Available from: https://doi.org/10.1161/CIRCULATIONAHA.117.030950
Artigo de periodico-carta/editorial
Building the Future of Trial Design in PAH on Solid Ground (2018)
Souza, Rogerio
Source: Chest. Unidade: FM
Subjects: HIPERTENSÃO PULMONAR, FARMACOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Rogerio. Building the Future of Trial Design in PAH on Solid Ground. Chest. Amsterdam: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.chest.2018.01.041. Acesso em: 22 jan. 2026. , 2018
APA
Souza, R. (2018). Building the Future of Trial Design in PAH on Solid Ground. Chest. Amsterdam: Faculdade de Medicina, Universidade de São Paulo. doi:10.1016/j.chest.2018.01.041
NLM
Souza R. Building the Future of Trial Design in PAH on Solid Ground [Internet]. Chest. 2018 ; 153( 5): 1089-1090.[citado 2026 jan. 22 ] Available from: https://doi.org/10.1016/j.chest.2018.01.041
Vancouver
Souza R. Building the Future of Trial Design in PAH on Solid Ground [Internet]. Chest. 2018 ; 153( 5): 1089-1090.[citado 2026 jan. 22 ] Available from: https://doi.org/10.1016/j.chest.2018.01.041
Artigo de periodico
Survival of patients with schistosomiasis-associated pulmonary arterial hypertension in the modern management era (2018)
Fernandes, Caio Julio Cesar; Souza, Rogerio; PILOTO, Bruna; CASTRO, Marcela; OLEAS, Francisca Gavilanes; ALVES JR., Jose Leonidas; PRADA, Luis Felipe Lopes; JARDIM, Carlos
Source: European respiratory journal. Unidade: FM
Subjects: ESQUISTOSSOMOSE, HIPERTENSÃO PULMONAR, SOBREVIDA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERNANDES, Caio Julio Cesar et al. Survival of patients with schistosomiasis-associated pulmonary arterial hypertension in the modern management era. European respiratory journal, v. 51, n. 6, 2018Tradução . . Disponível em: https://doi.org/10.1183/13993003.00307-2018. Acesso em: 22 jan. 2026.
APA
Fernandes, C. J. C., Souza, R., PILOTO, B., CASTRO, M., OLEAS, F. G., ALVES JR., J. L., et al. (2018). Survival of patients with schistosomiasis-associated pulmonary arterial hypertension in the modern management era. European respiratory journal, 51( 6). doi:10.1183/13993003.00307-2018
NLM
Fernandes CJC, Souza R, PILOTO B, CASTRO M, OLEAS FG, ALVES JR. JL, PRADA LFL, JARDIM C. Survival of patients with schistosomiasis-associated pulmonary arterial hypertension in the modern management era [Internet]. European respiratory journal. 2018 ; 51( 6):[citado 2026 jan. 22 ] Available from: https://doi.org/10.1183/13993003.00307-2018
Vancouver
Fernandes CJC, Souza R, PILOTO B, CASTRO M, OLEAS FG, ALVES JR. JL, PRADA LFL, JARDIM C. Survival of patients with schistosomiasis-associated pulmonary arterial hypertension in the modern management era [Internet]. European respiratory journal. 2018 ; 51( 6):[citado 2026 jan. 22 ] Available from: https://doi.org/10.1183/13993003.00307-2018
Artigo de periodico
Anti-Inflammatory Therapy With Canakinumab for the Prevention and Management of Diabetes (2018)
Everett, Brendan M.; Nicolau, Jose C.; DONATH, Marc Y.; PRADHAN, Aruna D.; THUREN, Tom; PAIS, Prem; GLYNN, Robert J; LIBBY, Peter; RIDKER, Paul M.
Source: Journal of the american college of cardiology. Unidade: FM
Subjects: ANTI-INFLAMATÓRIOS, DOENÇAS CARDIOVASCULARES, DIABETES MELLITUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
EVERETT, Brendan M. et al. Anti-Inflammatory Therapy With Canakinumab for the Prevention and Management of Diabetes. Journal of the american college of cardiology, v. 71, n. 21, p. 2392-2401, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.jacc.2018.03.002. Acesso em: 22 jan. 2026.
APA
Everett, B. M., Nicolau, J. C., DONATH, M. Y., PRADHAN, A. D., THUREN, T., PAIS, P., et al. (2018). Anti-Inflammatory Therapy With Canakinumab for the Prevention and Management of Diabetes. Journal of the american college of cardiology, 71( 21), 2392-2401. doi:10.1016/j.jacc.2018.03.002
NLM
Everett BM, Nicolau JC, DONATH MY, PRADHAN AD, THUREN T, PAIS P, GLYNN RJ, LIBBY P, RIDKER PM. Anti-Inflammatory Therapy With Canakinumab for the Prevention and Management of Diabetes [Internet]. Journal of the american college of cardiology. 2018 ; 71( 21): 2392-2401.[citado 2026 jan. 22 ] Available from: https://doi.org/10.1016/j.jacc.2018.03.002
Vancouver
Everett BM, Nicolau JC, DONATH MY, PRADHAN AD, THUREN T, PAIS P, GLYNN RJ, LIBBY P, RIDKER PM. Anti-Inflammatory Therapy With Canakinumab for the Prevention and Management of Diabetes [Internet]. Journal of the american college of cardiology. 2018 ; 71( 21): 2392-2401.[citado 2026 jan. 22 ] Available from: https://doi.org/10.1016/j.jacc.2018.03.002
Artigo de periodico
ESRD After Heart Failure, Myocardial Infarction, or Stroke in Type 2 Diabetic Patients With CKD (2017)
Charytan, David M.; Burdmann, Emmanuel de Almeida
Source: American journal of kidney diseases. Unidade: FM
Subjects: FALÊNCIA RENAL CRÔNICA, DOENÇAS CARDIOVASCULARES, DIABETES MELLITUS, INFARTO DO MIOCÁRDIO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CHARYTAN, David M. e BURDMANN, Emmanuel de Almeida. ESRD After Heart Failure, Myocardial Infarction, or Stroke in Type 2 Diabetic Patients With CKD. American journal of kidney diseases, v. 70, n. 4, p. 522-531, 2017Tradução . . Disponível em: http://observatorio.fm.usp.br/handle/OPI/21785. Acesso em: 22 jan. 2026.
APA
Charytan, D. M., & Burdmann, E. de A. (2017). ESRD After Heart Failure, Myocardial Infarction, or Stroke in Type 2 Diabetic Patients With CKD. American journal of kidney diseases, 70( 4), 522-531. doi:10.1053/j.ajkd.2017.04.018
NLM
Charytan DM, Burdmann E de A. ESRD After Heart Failure, Myocardial Infarction, or Stroke in Type 2 Diabetic Patients With CKD [Internet]. American journal of kidney diseases. 2017 ; 70( 4): 522-531.[citado 2026 jan. 22 ] Available from: http://observatorio.fm.usp.br/handle/OPI/21785
Vancouver
Charytan DM, Burdmann E de A. ESRD After Heart Failure, Myocardial Infarction, or Stroke in Type 2 Diabetic Patients With CKD [Internet]. American journal of kidney diseases. 2017 ; 70( 4): 522-531.[citado 2026 jan. 22 ] Available from: http://observatorio.fm.usp.br/handle/OPI/21785
Artigo de periodico
World Heart Federation Cholesterol Roadmap (2017)
Murphy, A.; Santos Filho, Raul Dias dos
Source: Global heart. Unidade: FM
Subjects: COLESTEROL, DOENÇAS CARDIOVASCULARES, POLÍTICAS PÚBLICAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MURPHY, A. e SANTOS FILHO, Raul Dias dos. World Heart Federation Cholesterol Roadmap. Global heart, v. 12, n. 3, p. 179-197.e5, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.gheart.2017.03.002. Acesso em: 22 jan. 2026.
APA
Murphy, A., & Santos Filho, R. D. dos. (2017). World Heart Federation Cholesterol Roadmap. Global heart, 12( 3), 179-197.e5. doi:10.1016/j.gheart.2017.03.002
NLM
Murphy A, Santos Filho RD dos. World Heart Federation Cholesterol Roadmap [Internet]. Global heart. 2017 ; 12( 3): 179-197.e5.[citado 2026 jan. 22 ] Available from: https://doi.org/10.1016/j.gheart.2017.03.002
Vancouver
Murphy A, Santos Filho RD dos. World Heart Federation Cholesterol Roadmap [Internet]. Global heart. 2017 ; 12( 3): 179-197.e5.[citado 2026 jan. 22 ] Available from: https://doi.org/10.1016/j.gheart.2017.03.002

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects

Source title

Countries/Territories

Funding Agencies